Back
Prelude Therapeutics Vs. Vericel Industry Stock Comparison
Sell
1
PRLD
Prelude Therapeutics
Last Price:
2.54
Seasonality Move:
-34.13%
Sell
29
VCEL
Vericel
Last Price:
48.02
Seasonality Move:
3.14%
Sell
1
Prelude Therapeutics (PRLD)
is a Sell
Is Prelude Therapeutics a Buy, Sell or Hold?
- The current Prelude Therapeutics [PRLD] share price is $2.44. The Score for PRLD is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- PRLD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Vericel (VCEL)
is a Sell
Is Vericel a Buy, Sell or Hold?
- The current Vericel [VCEL] share price is $46.35. The Score for VCEL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- VCEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRLD Stock Price Chart
What is Prelude Therapeutics's stock price today?
-
The Prelude Therapeutics share price today is $2.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.
VCEL Stock Price Chart
PRLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 27.29 | Sell |
| Chaikin Money Flow: | -252529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.8 - 5.84) | Sell |
| Bollinger Bands (100): | (3.55 - 5.41) | Sell |
VCEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.94 | Sell |
| Relative Strength Index (14 RSI): | 48.39 | Sell |
| Chaikin Money Flow: | 72527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.49 - 50.09) | Sell |
| Bollinger Bands (100): | (44.74 - 50.08) | Sell |
PRLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.8 | Sell |
| 20-day SMA: | 4.67 | Sell |
| 50-day SMA: | 5.13 | Sell |
| 200-day SMA: | 4.23 | Sell |
| 8-day EMA: | 3.45 | Sell |
| 20-day EMA: | 4.31 | Sell |
| 50-day EMA: | 4.7 | Sell |
| 200-day EMA: | 4.45 | Sell |
VCEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.59 | Buy |
| 20-day SMA: | 47.51 | Sell |
| 50-day SMA: | 48.24 | Sell |
| 200-day SMA: | 45.17 | Buy |
| 8-day EMA: | 45.43 | Buy |
| 20-day EMA: | 46.46 | Sell |
| 50-day EMA: | 47.23 | Sell |
| 200-day EMA: | 44.76 | Buy |
Prelude Therapeutics Earnings Growth & PRLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.02 per share, an increase this year of $0.22 per share, and an increase next year of $0.21 per share.
Vericel Earnings Growth & VCEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.10 per share, an increase this year of $0.29 per share, and an increase next year of $0.42 per share.
Prelude Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vericel Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||